Long-term sleep disturbance and prescription sleep aid use among cancer survivors in the United States

被引:40
作者
Slade, Alexander N. [1 ]
Waters, Michael R. [1 ]
Serrano, Nicholas A. [2 ]
机构
[1] Virginia Commonwealth Univ Hlth Syst, Massey Canc Ctr, Dept Radiat Oncol, Box 980058, Richmond, VA 23298 USA
[2] Overlake Med Ctr, Radiat Oncol, Bellevue, WA USA
关键词
Sleep disturbance; NHANES; Prescription sleep aid; Cancer survivorship; COGNITIVE-BEHAVIORAL THERAPY; JOINT CONSENSUS STATEMENT; BREAST-CANCER; RECOMMENDED AMOUNT; AMERICAN ACADEMY; HEALTHY ADULT; INSOMNIA; DEPRESSION; FATIGUE; MEDICINE;
D O I
10.1007/s00520-019-04849-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Insomnia and related sleep disorders are common complaints among cancer patients, and use of prescription sleep aids can be high in the treatment setting. The prevalence of sleep disturbance and prescription sleep aid use in the community-dwelling cancer survivorship population, however, remains relatively unexplored. We aim to ascertain the extent to which a cancer diagnosis is associated with sleep disturbances and prescription sleep aid use as measured in several cross sections of individuals across multiple disease sites and time since cancer diagnosis. Methods We used data from five cross-sectional cycles of the National Health and Nutrition Evaluation Survey (NHANES) from 2005 to 2014. We identified a total of 2371 individuals who reported a diagnosis of cancer (averaging 61 years old) and 25,788 individuals who did not report a cancer diagnosis (averaging 45 years old). We considered several patient-reported sleep-related outcomes. Multivariate regression analyses, as well as propensity score matching, were used to clarify the relationship between sleep disturbances, prescription sleep aid use, and cancer diagnosis, stratified by time since diagnosis and primary disease site. Results Reported sleep disturbance was common in cancer survivors, with approximately 34% of patients with a history of cancer reporting having ever been told they had trouble sleeping, compared to 23% of non-cancer patients in the general population with no history of cancer (p < 0.001). Propensity score matching supported a significantly higher rate of trouble sleeping among cancer survivors compared to matched controls. Compared to the general adult population without cancer, cancer survivors 11 or more years past diagnosis were more likely to report being diagnosed with trouble sleeping or a sleep disorder. Further, patients with gynecological cancers were more likely to report prescription sleep aid use, sleep disorders, and trouble sleeping compared to adults without a history of cancer. Conclusions Sleeping problems are common in the cancer survivorship population, especially in patients with a long survivorship history and a history of gynecological cancers. Consideration of symptoms of insomnia and sleep disturbance may be helpful in the follow-up care of these patients.
引用
收藏
页码:551 / 560
页数:10
相关论文
共 42 条
  • [1] New and chronic use of hypnotics after diagnosis with early breast cancer. A retrospective cohort study
    Andersen, Laerke Toftegard
    Suppli, Nis Palm
    Dalton, Susanne Oksbjerg
    Kroman, Niels
    Rosenberg, Jacob
    Gogenur, Ismail
    [J]. ACTA ONCOLOGICA, 2015, 54 (05) : 704 - 711
  • [2] Propensity score matching and complex surveys
    Austin, Peter C.
    Jembere, Nathaniel
    Chiu, Maria
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2018, 27 (04) : 1240 - 1257
  • [3] Inflammatory responses to psychological stress in fatigued breast cancer survivors: Relationship to glucocorticoids
    Bower, Julienne E.
    Ganz, Patricia A.
    Aziz, Najib
    Olmstead, Richard
    Irwin, Michael R.
    Cole, Steve W.
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 2007, 21 (03) : 251 - 258
  • [4] Inflammation and Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, and Sleep Disturbance Share a Common Underlying Mechanism?
    Bower, Julienne E.
    Ganz, Patricia A.
    Irwin, Michael R.
    Kwan, Lorna
    Breen, Elizabeth C.
    Cole, Steve W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (26) : 3517 - 3522
  • [5] Differences in Sleep Disturbance Parameters Between Oncology Outpatients and Their Family Caregivers
    Carney, Sara
    Koetters, Theresa
    Cho, Maria
    West, Claudia
    Paul, Steven M.
    Dunn, Laura
    Aouizerat, Bradley E.
    Dodd, Marylin
    Cooper, Bruce
    Lee, Kathryn
    Wara, William
    Swift, Patrick
    Miaskowski, Christine
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (08) : 1001 - 1006
  • [6] Acupuncture for Managing Cancer-Related Insomnia: A Systematic Review of Randomized Clinical Trials
    Choi, Tae-Young
    Kim, Jong In
    Lim, Hyun-Ja
    Lee, Myeong Soo
    [J]. INTEGRATIVE CANCER THERAPIES, 2017, 16 (02) : 135 - 146
  • [7] Chong Y, 2013, NCHS DATA BRIEF, V127, P1
  • [8] Sleep quality in individuals diagnosed with colorectal cancer: Factors associated with sleep disturbance as patients transition off treatment
    Coles, Theresa
    Tan, Xianming
    Bennett, Antonia V.
    Sanoff, Hanna K.
    Basch, Ethan
    Jensen, Roxanne E.
    Reeve, Bryce B.
    [J]. PSYCHO-ONCOLOGY, 2018, 27 (03) : 1050 - 1056
  • [9] Sleep Aid Prescribing Practices during Neoadjuvant or Adjuvant Chemotherapy for Breast Cancer
    Costantini, Carrie
    Ale-Ali, Amine
    Helsten, Teresa
    [J]. JOURNAL OF PALLIATIVE MEDICINE, 2011, 14 (05) : 563 - 566
  • [10] Long-term and Short-term Effects of Insomnia in Cancer and Effective Interventions
    Davis, Mellar P.
    Goforth, Harold W.
    [J]. CANCER JOURNAL, 2014, 20 (05) : 330 - 344